Autopsy report · NCT02039778

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Poor Accural”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month after it had already started.
Ran for about 2 years before it stopped.
4 participants enrolled.
Results were posted on the registry 1 year 6 months after it ended.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Beth Israel Medical Center
Sponsor type: University, hospital or other
Conditions: Glioblastoma; Malignant Glioma; Brain Tumors; Anaplastic Astrocytoma
Interventions: Stem Cell Radiotherapy (ScRT) and Temozolomide
Participants: 4
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.